Your account is not claimed yet. You can sign up with ORCID to claim your account.

Ulrika Wählby-Hamrén (Ulrika Wählby Hamrén)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Venues

Nature medicine

International journal of chronic obstructive pulmonary disease

American journal of respiratory and critical care medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Deidre Wilkins, Yuan Yuan, Yue Chang, Anastasia A Aksyuk, Beatriz Seoane Núñez, Ulrika Wählby-Hamrén, Tianhui Zhang, Michael E Abram, Amanda Leach, Tonya Villafana, Mark T Esser
Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants. Nature medicine (2023)
Deidre Wilkins, Yuan Yuan, Yue Chang, Anastasia A Aksyuk, Beatriz Seoane Núñez, Ulrika Wählby-Hamrén, Tianhui Zhang, Michael E Abram, Amanda Leach, Tonya Villafana, Mark T Esser
Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants. Nature medicine (2023)
Deidre Wilkins, Yuan Yuan, Yue Chang, Anastasia A Aksyuk, Beatriz Seoane Núñez, Ulrika Wählby-Hamrén, Tianhui Zhang, Michael E Abram, Amanda Leach, Tonya Villafana, Mark T Esser
Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants. Nature medicine 29 (5) (2023)
Deidre Wilkins, Yuan Yuan, Yue Chang, Anastasia A Aksyuk, Beatriz Seoane Núñez, Ulrika Wählby-Hamrén, Tianhui Zhang, Michael E Abram, Amanda Leach, Tonya Villafana, Mark T Esser
Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants. Nature medicine (2023)
Kirill Zhudenkov, Robert Palmér, Alexandra Jauhiainen, Gabriel Helmlinger, Oleg Stepanov, Kirill Peskov, Ulf G Eriksson, Ulrika Wählby-Hamrén
Longitudinal FEV1 and Exacerbation Risk in COPD: Quantifying the Association Using Joint Modelling. International journal of chronic obstructive pulmonary disease 16 (2021)
Dave Singh, Rainard Fuhr, Lali Jimenez, Ulrika Wählby-Hamrén, Alexandra Jauhiainen, Marie-Pierre Malice, Victor Balaguer, Alejhandra Lei, Ajay Aggarwal, Carol Astbury, Ioannis Psallidas
A Randomized Trial of Dual-Acting Bronchodilator AZD8871 for Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine 199 (10) (2020)

Ulrika Wählby-Hamrén.css-eqlu8i{font-size:small;padding-left:4px;} (Ulrika Wählby Hamrén)

Publication Activity (10 Years)

Top Topics

Top Venues

Ulrika Wählby-Hamrén (Ulrika Wählby Hamrén)